A 2006 recommendation from the Advisory Committee on Immunization Practices details the routine use of a three-dose rotavirus vaccine for U.S. infants. The document specifies dosing schedules, age windows, and contraindications for the RotaTeq vaccine. It was authored by Umesh D. Parashar of the National Center for Immunization and Respiratory Diseases.
Use Cases
- Analyzing vaccination schedules based on the specified age windows of 2, 4, and 6 months.
- Studying vaccine co-administration policies based on the mention of compatibility with other childhood vaccines.
- Identifying contraindications for rotavirus vaccination based on described allergic reaction criteria.
Strengths
- Provides specific age windows for vaccine administration, such as the first dose between 6-12 weeks.
- Details a concrete three-dose regimen with defined intervals of 4-10 weeks.
- Originates from an authoritative public health body, the Advisory Committee on Immunization Practices.
Limitations
- Row count is unknown, which may limit suitability assessment.
- Column-level documentation is absent; field semantics must be inferred after download.
- Last update date is unknown; freshness unverified.
Provenance
- Source
- National Center for Immunization and Respiratory Diseases
- Collection Method
- Policy recommendation document.
- Time Range
- 2006
- Geography
- United States